# Comparison of Hepatus and FibroScan for Evaluation of Fibrosis and Steatosis

> **NCT05786963** · — · UNKNOWN · sponsor: **Beijing Friendship Hospital** · enrollment: 400 (estimated)

## Conditions studied

- Chronic Hepatitis b
- Non-Alcoholic Fatty Liver Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05786963
- **Lead sponsor:** Beijing Friendship Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-12-29
- **Primary completion:** 2023-12
- **Final completion:** 2024-04
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2023-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05786963

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05786963, "Comparison of Hepatus and FibroScan for Evaluation of Fibrosis and Steatosis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05786963. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*